Pilot Study Using a Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Hemodialysis Ultrafiltration
Primary Purpose
Intradialytic Hypotension, Hypervolemia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Place dialysis chair into position 3.
Decrease dialysate temperature.
Decrease ultrafiltration rate by 25%.
Decrease ultrafiltration rate by 50%.
Sponsored by
About this trial
This is an interventional prevention trial for Intradialytic Hypotension
Eligibility Criteria
Inclusion Criteria:
- Age >18 years
- On dialysis > 6 months with a stable dialysis program
- Consistent achievement of a spKt/V ≥ 1.2
- HGB ≥ 10 gm% ± ESA support
- Consistent failure to achieve a post weight ≤ dry weight + 0.5Kg
- Able to give informed consent directly
Frequent hypotensive reactions (≥ 1 / treatment in 4 of last 8 treatments)
- Symptoms of hypotension
- Intervention administered because of IDH (saline, "turn downs, early termination, trendelenberg position)
- Drop in BP irrespective of symptoms. SBP < 90 mmHG intra or post HD if pre SBP was > 110 mmHG; SBP < 85 mmHG or 15 mmHG drop from start if starting BP ≤ 110 mmHG.
- Or judged by the nursing staff to be difficult to achieve dry weight.
Exclusion Criteria:
- Dialysis Catheter Access that may interfere with continuous data collection, per PI determination. (Catheter access is a relative exclusion based on the history of catheter performance.)
- Cognitive Impairment precluding cooperation, and consent
- Restless or unlikely to wear the monitor head-band
- Too unstable in the judgment of their nephrologist to be included in a study of this nature.
Sites / Locations
- Centers for Dialysis Care - East
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Single Arm
Arm Description
All patients will be enrolled in the same intervention arm. Interventions are implemented based in 1-4 event levels on the device. Interventions include: "Place dialysis chair into position 3", "Decrease dialysate temperature", "Decrease ultrafiltration rate by 25%", and "Decrease ultrafiltration rate by 50%".
Outcomes
Primary Outcome Measures
Difference between prescribed dry weight and actual measured weight at end of dialysis session.
Percent difference between prescribed dry weight and actual weight at end of dialysis session.
Secondary Outcome Measures
Full Information
NCT ID
NCT02264522
First Posted
September 22, 2014
Last Updated
August 28, 2016
Sponsor
Intelomed, Inc.
Collaborators
Centers for Dialysis Care, Inc
1. Study Identification
Unique Protocol Identification Number
NCT02264522
Brief Title
Pilot Study Using a Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Hemodialysis Ultrafiltration
Official Title
Use of Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Ultrafiltration in Hemodialysis Patients to Achieve Euvolemia While Minimizing Intra-dialytic Hypotension
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
September 2014 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
August 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Intelomed, Inc.
Collaborators
Centers for Dialysis Care, Inc
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to use the photo-plethysmographic [PPG] waveform signal to guide the dialysis and ultrafiltration [UF] of chronic maintenance hemodialysis patients, and to further the investigators understanding of homeostasis in hemodialysis.
The investigators hypothesize that the signals generated from the PPG device along with traditional monitoring and nursing judgment, will allow experienced, oriented staff to anticipate hemodynamic instability, intervene to prevent or mitigate the intradialytic hypotention [IDH], forestalling the onset of non-facilitating compensatory reflexes that preclude the patient from achieving an appropriate post-dialysis weight consistent with euvolemia. Furthermore, it is hypothesized that the nephrologist and staff will be able to wean patients from anti-hypertensive medications and craft patient specific dialysis orders and UF profiles that achieve consistent, comfortable treatment to appropriate end points.
The study aims include:
Aim 1: To confirm the temporal sequence of PPG signals and changes in BP in routine hemodialysis.
Aim 2: To refine further the predictive algorithms of PPG, augmented with continuous cardiac event monitoring (pre-intra-post hemodialysis) Aim 3: To develop targeted interventions to reverse the cardiovascular stress indicated by the PPG and to maintain perfusion.
Aim 4: To develop care paths approved by the medical staff and primary care nephrologist allowing RNs to respond to signals from the PPG.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intradialytic Hypotension, Hypervolemia
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Single Arm
Arm Type
Experimental
Arm Description
All patients will be enrolled in the same intervention arm. Interventions are implemented based in 1-4 event levels on the device. Interventions include: "Place dialysis chair into position 3", "Decrease dialysate temperature", "Decrease ultrafiltration rate by 25%", and "Decrease ultrafiltration rate by 50%".
Intervention Type
Other
Intervention Name(s)
Place dialysis chair into position 3.
Intervention Description
Upon device notification event 1, place patient in dialysis chair position 3.
Intervention Type
Other
Intervention Name(s)
Decrease dialysate temperature.
Intervention Description
Upon device notification event 2, decrease dialysate temperature by 0.5 degree centigrade.
Intervention Type
Other
Intervention Name(s)
Decrease ultrafiltration rate by 25%.
Intervention Description
Upon device notification event 3, decrease ultrafiltration rate by 25% from baseline ultrafiltration rate.
Intervention Type
Other
Intervention Name(s)
Decrease ultrafiltration rate by 50%.
Intervention Description
Upon device notification event 4, decrease ultrafiltration rate by 50% from baseline ultrafiltration rate.
Primary Outcome Measure Information:
Title
Difference between prescribed dry weight and actual measured weight at end of dialysis session.
Description
Percent difference between prescribed dry weight and actual weight at end of dialysis session.
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age >18 years
On dialysis > 6 months with a stable dialysis program
Consistent achievement of a spKt/V ≥ 1.2
HGB ≥ 10 gm% ± ESA support
Consistent failure to achieve a post weight ≤ dry weight + 0.5Kg
Able to give informed consent directly
Frequent hypotensive reactions (≥ 1 / treatment in 4 of last 8 treatments)
Symptoms of hypotension
Intervention administered because of IDH (saline, "turn downs, early termination, trendelenberg position)
Drop in BP irrespective of symptoms. SBP < 90 mmHG intra or post HD if pre SBP was > 110 mmHG; SBP < 85 mmHG or 15 mmHG drop from start if starting BP ≤ 110 mmHG.
Or judged by the nursing staff to be difficult to achieve dry weight.
Exclusion Criteria:
Dialysis Catheter Access that may interfere with continuous data collection, per PI determination. (Catheter access is a relative exclusion based on the history of catheter performance.)
Cognitive Impairment precluding cooperation, and consent
Restless or unlikely to wear the monitor head-band
Too unstable in the judgment of their nephrologist to be included in a study of this nature.
Facility Information:
Facility Name
Centers for Dialysis Care - East
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Pilot Study Using a Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Hemodialysis Ultrafiltration
We'll reach out to this number within 24 hrs